Skip to main content

Aetiology of Respiratory Tract Infections in Adults in Europe: Current Knowledge and Knowledge Gaps

  • Chapter
  • First Online:
  • 709 Accesses

Part of the book series: Practical Issues in Geriatrics ((PIG))

Abstract

Respiratory diseases represent the third most common cause of death in Europe, including both chronic lower respiratory diseases and pneumonia, while lower respiratory infections remain the most deadly communicable disease. With worldwide population ageing, it is expected that the burden of infections such as community-acquired pneumonia (CAP) will continue to increase in the coming years, with the vast majority of deaths occurring among those aged 65 years or more. A wide range of host factors are involved in the aetiology of respiratory tract infections, including anatomical and functional changes that occur with ageing. In addition, atypical presentation of symptoms in the elderly can often make the diagnosis of respiratory diseases, such as pneumonia, more difficult in older adults. Also, identifying the pathogens responsible for infection can often be difficult, with no benefit to be yielded from systematic microbiological sampling. Vaccination is an important measure to prevent pneumococcal diseases and influenza in older adults and to reduce mortality from these diseases.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. World Health Organisation. The top 10 causes of death. 2017. http://www.who.int/mediacentre/factsheets/fs310/en/. Accessed 7 Aug 2017.

  2. Vanden Abbeele A, de Meel H, Ahariz M, et al. Denture contamination by yeasts in the elderly. Gerodontology. 2008;25:222–8.

    Article  Google Scholar 

  3. Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14:428–36.

    Article  CAS  Google Scholar 

  4. Janssens JP, Krause KH. Pneumonia in the very old. Lancet Infect Dis. 2004;4:112–24.

    Article  Google Scholar 

  5. Faverio P, Aliberti S, Bellelli G, et al. The management of community-acquired pneumonia in the elderly. Eur J Intern Med. 2014;25:312–9.

    Article  Google Scholar 

  6. Putot A, Tetu J, Perrin S, et al. Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients. Eur J Clin Microbiol Infect Dis. 2016;35:489–95.

    Article  CAS  Google Scholar 

  7. Gadsby NJ, Russell CD, McHugh MP, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62:817–23.

    Article  CAS  Google Scholar 

  8. Jones RN, Sader HS, Moet GJ, et al. Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY antimicrobial surveillance program (1998–2009). Diagn Microbiol Infect Dis. 2010;68:334–6.

    Article  Google Scholar 

  9. Hauser C, Kronenberg A, Allemann A, et al. (2016) Serotype/serogroup-specific antibiotic non-susceptibility of invasive and non-invasive streptococcus pneumoniae, Switzerland, 2004–2014. Euro Surveill. 21(21). https://doi.org/10.2807/1560-7917.ES.2016.21.21.30239.

  10. Bonten MJ, Huijts SM, Bolkenbaas M, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med. 2015;372:1114–25.

    Article  CAS  Google Scholar 

  11. Diao WQ, Shen N, Yu PX, et al. Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: a systematic review and meta-analysis of randomized trials. Vaccine. 2016;34:1496–503.

    Article  CAS  Google Scholar 

  12. Kraicer-Melamed H, O'Donnell S, Quach C. The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: a systematic review and meta-analysis. Vaccine. 2016;34:1540–50.

    Article  CAS  Google Scholar 

  13. Christenson B, Hedlund J, Lundbergh P, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J. 2004;23:363–8.

    Article  CAS  Google Scholar 

  14. Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virol J. 2008;5:52.

    Article  Google Scholar 

  15. Mahamat A, Daures JP, de Wzieres B. Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study. Hum Vaccin Immunother. 2013;9:128–35.

    Article  CAS  Google Scholar 

  16. Zhang YY, Tang XF, Du CH, et al. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: a meta-analysis. Hum Vaccin Immunother. 2016;12:3056–64.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ingo Beyer .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Beyer, I. (2019). Aetiology of Respiratory Tract Infections in Adults in Europe: Current Knowledge and Knowledge Gaps. In: Michel, JP., Maggi, S. (eds) Adult Vaccinations. Practical Issues in Geriatrics. Springer, Cham. https://doi.org/10.1007/978-3-030-05159-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-05159-4_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-05158-7

  • Online ISBN: 978-3-030-05159-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics